Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2017

View Archived Issues

Metacrine tests new farnesoid X-activated receptor agonist in NASH model

Armanezumab clears pathological Tau protein in mouse brains

Procathepsin D found as a diagnostic marker of malignant pleural effusion in lung cancer

Hepcidin knockout rats display iron overload

European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma

Adaptimmune Therapeutics begins AFP SPEAR T-cell study in HCC

FDA grants breakthrough therapy designation to vonapanitase from Proteon Therapeutics

First patient enrolled in phase I trial of Loxo Oncology's LOXO-292

Takeda and GammaDelta Therapeutics announce strategic collaboration

Leucyl-tRNA synthetase inhibitor from Dong-A ST potently inhibits Gram-negative bacteria

Polymorphism in ADRB1 impacts outcome in Marfan syndrome patients on atenolol

FDA grants fast track designation to Celyad's C-Cure

Astellas discontinues ASP-8273 treatment in SOLAR NSCLC trial

Vericel's ixmyelocel-T wins FDA regenerative medicine advanced therapy designation

Companies partner on E.U. managed access programs for niraparib and belinostat

A new rabbit model of respiratory distress syndrome managed on nCPAP

Savara receives FDA guidance on clinical requirements for Molgradex NDA

Longeveron cleared to continue phase I trial of LMSCs in Alzheimer's disease

Topline data reported from pivotal studies of mepolizumab for severe COPD

Shionogi reflects on accomplishments of fourth quarter of fiscal 2016

Jortan Pharmaceuticals discovers beta-secretase 2 inhibitors

NSAID derivatives patented by ratiopharm

AbGenomics initiates phase I study of ADC AbGn-107 in gastric, colorectal and pancreatic cancer

Sangamo and Pfizer collaborate on gene therapy programs for hemophilia A

FDA approves Keytruda in first-line combination therapy for metastatic nonsquamous NSCLC

Servier initiates phase I study of S-64315 in AML and MDS

Polymorphisms of the Wnt pathway associated with bronchopulmonary dysplasia in ELBW infants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...